Biological materials typically display
complex morphologies and
hierarchical architectures, properties that are hardly matched by
synthetic materials. Understanding the biological control of mineral
properties will enable the development of new synthetic approaches
toward biomimetic functional materials. Here, we combine biocombinatorial
approaches with a proteome homology search and in vitro mineralization
assays to assess the role of biological determinants in biomimetic
magnetite mineralization. Our results suggest that the identified
proteins and biomimetic polypeptides influence nucleation in vitro.
Even though the in vivo role cannot be directly determined from our
experiments, we can rationalize the following design principles: proteins,
larger complexes, or membrane components that promote nucleation in
vivo are likely to expose positively charged residues to a negatively
charged crystal surface. In turn, components with acidic (negatively
charged) functionality are nucleation inhibitors, which stabilize
an amorphous structure through the coordination of iron.